IRDAI approves Axis Bank's capital infusion into Max Life
Insurance regulator, IRDAI has approved the capital infusion by Axis Bank into Max Life, subject to the approval of the competition watchdog CCI.
Stay updated with breaking news from Ortfolio Allocation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Insurance regulator, IRDAI has approved the capital infusion by Axis Bank into Max Life, subject to the approval of the competition watchdog CCI.
Market regulator Securities and Exchange Board of India (SEBI) has asked Anirudh Sethi, director and designated person of Alexander Stamps and Coin Ltd (erstwhile Rudraksh Cap Tech Ltd) (ASCL), to disgorge Rs1.18 crore earned by him as profit from contra trades. SEBI asked him to remit the money to the investor protection and education fund (IPEF) administered by the market regulator.
On Wednesday, 2245 stocks advanced, 1633 declined and 81 remained unchanged, with an advance decline ratio of 1.37 on the Bombay Stock Exchange (BSE), indicating positive closing of stocks in broader markets.
Criticising market regulator Securities and Exchange Board of India (SEBI) for its sluggish approach in handling a case, the Supreme Court rapped SEBI for taking 10 years to conclude an investigation into a case involving alleged violation of listing norms and unfair trade practice. Last year also, the apex court had pulled up SEBI for issuing a show-cause notice (SCN) after a 10-year probe in the Alps Motor Finance Ltd (AMFL) case.
Reserve Bank of India (RBI) has approved an application filed by HDFC Bank Ltd as promoter and sponsor of HDFC Bank group to acquire aggregate holding of up to 9.50% of the share capital or voting rights in six banks. It includes Axis Bank Ltd, Suryoday Small Finance Bank Ltd, ICICI Bank Ltd, Bandhan Bank Ltd, Yes Bank Ltd and IndusInd Bank Ltd.